|
Re: Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders
|
6
|
Resverlogix Corp.
|
Sep 14, 2018 06:50PM
|
|
Re: BETonMACE and Aminotransferases
|
6
|
Resverlogix Corp.
|
Aug 14, 2019 04:04PM
|
|
ZEN-3694 mCRPC Trial Status
|
6
|
Zenith Epigenetics
|
Oct 24, 2017 11:18AM
|
|
Re: Amarin CEO interview
|
6
|
Resverlogix Corp.
|
Nov 12, 2018 03:02PM
|
|
Re: Looking at the language from the press release
|
6
|
Resverlogix Corp.
|
Oct 05, 2019 02:43PM
|
|
Re: We got the late-breaker :)
|
6
|
Resverlogix Corp.
|
Feb 18, 2020 02:31PM
|
|
On or about September 30, 2019
|
6
|
Resverlogix Corp.
|
Sep 25, 2019 10:22AM
|
|
Re: ... this from our girl in IR...
|
6
|
Resverlogix Corp.
|
Jun 08, 2018 05:28PM
|
|
Re: Private placement
|
6
|
Resverlogix Corp.
|
Aug 30, 2018 08:55AM
|
|
Re: Apabetalone for non diabetics or normal cholesterol?
|
6
|
Resverlogix Corp.
|
Dec 10, 2019 02:32PM
|
|
Re: Compilation of BET inhibitor Trials
|
6
|
Zenith Epigenetics
|
Nov 30, 2017 10:54AM
|
|
Re: Apabetalone for non diabetics or normal cholesterol?
|
6
|
Resverlogix Corp.
|
Dec 10, 2019 02:35PM
|
|
Zenith hiring Senior Director of Clinical Operations
|
6
|
Resverlogix Corp.
|
Dec 01, 2015 11:50AM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Sep 22, 2018 05:58PM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
6
|
Resverlogix Corp.
|
Dec 02, 2019 08:46AM
|
|
Re: FA and FDA
|
6
|
Resverlogix Corp.
|
Jun 28, 2017 02:37PM
|
|
Amarin
|
6
|
Resverlogix Corp.
|
Apr 04, 2018 09:03PM
|
|
Re: AHA late breaking abstract
|
6
|
Resverlogix Corp.
|
Nov 11, 2019 10:50AM
|
|
Re: Amarin Stock Halted pending FDA meeting today
|
6
|
Resverlogix Corp.
|
Nov 14, 2019 07:58PM
|
|
Endpoint News BET Inhibitors
|
6
|
Zenith Epigenetics
|
Mar 27, 2018 08:21PM
|
